Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasodilators in left ventricular failure.

F Camerini, L Mestroni, R Neri

    Giornale Italiano Di Cardiologia
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Histopathology of the muscle in rheumatic diseases.

    Reumatismo·2018
    Same author

    Genetics of Dilated Cardiomyopathy: Clinical Implications.

    Current cardiology reports·2018
    Same author

    The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature.

    Reumatismo·2018
    Same author

    Sub-arcsecond imaging of the water emission in Arp 220.

    Astronomy and astrophysics·2017
    Same author

    The alexander surgical technique for the treatment of severe burns.

    Annals of burns and fire disasters·2017
    Same author

    ALMA high spatial resolution observations of the dense molecular region of NGC 6302.

    Astronomy and astrophysics·2016
    Same journal

    [Proceedings of the National Cardiology Conference on Cardiac Emergencies: Prospect for the year 2000. Rome, Italy, 15-16 October 1999].

    Giornale italiano di cardiologia·2001
    Same journal

    [Heart rupture in acute myocardial infarction: advantages of the use of Doppler color echocardiography M-2D in coronary intensive care unit].

    Giornale italiano di cardiologia·2000
    Same journal

    [Risk identification and strategy for the prevention of sudden cardiac death after myocardial infarction].

    Giornale italiano di cardiologia·2000
    Same journal

    [Arrhythmic complications in patients with heart decompensation: when and how to treat].

    Giornale italiano di cardiologia·2000
    Same journal

    [Suboptimal exercise test in chronic heart decompensation: the six-minute walking test].

    Giornale italiano di cardiologia·2000
    Same journal

    [Orthostatic tachycardia syndrome. Update on etiology, diagnosis and treatment].

    Giornale italiano di cardiologia·2000
    See all related articles

    Vasodilator drugs, classified by action site, aid heart failure by reducing resistance or filling pressures. While hemodynamic studies guide choices, long-term prognosis impact remains unclear, though symptom relief is evident.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Vasodilator drugs are crucial in managing heart failure.
    • Classification is based on primary action: arteriolar, venodilator, or balanced.

    Purpose of the Study:

    • To review vasodilator drug classification and therapeutic indications in heart failure.
    • To discuss the role of hemodynamic and non-invasive studies in drug selection.
    • To examine the impact of vasodilator therapy on heart failure prognosis.

    Main Methods:

    • Review of existing literature on vasodilator pharmacology and clinical application.
    • Analysis of drug classification based on site of action (arteriolar, venodilator, balanced).
    • Discussion of diagnostic tools for evaluating vasodilator efficacy.

    Related Experiment Videos

    Main Results:

    • Vasodilators reduce peripheral resistance (arteriolar) or filling pressures (venodilator).
    • Indications include impaired contractility and volume overload heart failure.
    • Hemodynamic studies are vital for acute drug selection, but long-term prediction is limited.
    • Non-invasive methods like echocardiography are insufficient for therapy evaluation.

    Conclusions:

    • Vasodilator therapy is indicated for specific heart failure types.
    • Hemodynamic assessment is key for acute drug choice.
    • Long-term prognostic impact, especially survival, is uncertain, but symptom improvement and exercise tolerance are observed.